NAD Injection in San Antonio: What the Science Says

NAD injection therapy in San Antonio refers to subcutaneous or intramuscular delivery of nicotinamide adenine dinucleotide, a coenzyme central to cellular energy metabolism and DNA repair. Most published clinical evidence involves oral precursors such as NR and NMN, and data specifically on injectable NAD+ remains preliminary. Eligibility, dosing, and protocol are determined by a licensed clinician.

NAD injection in San Antonio sits at the intersection of cellular biology and longevity medicine. The coenzyme fuels mitochondrial energy production and DNA repair, and tissue levels appear to decline with age. Texans considering this therapy ask the same two questions: what does the research actually show, and who is a candidate?

What NAD+ Does in the Body

Nicotinamide adenine dinucleotide is present in every living cell. It shuttles electrons between metabolic reactions, switching between NAD+ and its reduced form NADH inside mitochondria. Without it, oxidative phosphorylation — the process generating roughly 90% of the body's ATP — cannot proceed.

Beyond energy metabolism, NAD+ is consumed by three enzyme families that have drawn intense research interest:

• Sirtuins (SIRT1–SIRT7), regulators of gene expression, mitochondrial biogenesis, and stress responses
• PARPs (poly-ADP-ribose polymerases), which detect and repair DNA damage
• CD38, an immune-signaling enzyme whose activity rises with age

Cellular NAD+ levels appear to decline with chronological age in animal models and human tissue samples, though magnitude varies by cell type and methodology (Imai & Guarente, Trends in Cell Biology, 2014). That observation is the biological premise behind every commercial NAD+ therapy on the market — including the injectable formulations dispensed through telehealth and functional-medicine clinics across South Texas.

What the Research Actually Shows

Most rigorous human data on raising NAD+ involves oral precursors, not injections of NAD+ itself. The two most-studied are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN).

In a randomized, double-blind, placebo-controlled trial, Martens and colleagues showed that 1,000 mg per day of NR for six weeks raised whole-blood NAD+ concentrations by roughly 60% in healthy middle-aged and older adults, with no significant adverse events compared with placebo (Martens et al., Nature Communications, 2018). Earlier pharmacokinetic work from the Brenner laboratory established that NR is rapidly absorbed and metabolized to NAD+ in human tissues (Trammell et al., Nature Communications, 2016).

For NMN, a 2021 trial led by Yoshino at Washington University reported that 250 mg of oral NMN daily for ten weeks improved skeletal muscle insulin sensitivity in postmenopausal women with prediabetes (Yoshino et al., Science, 2021). A Phase I trial of NR in Parkinson's disease (NADPARK) showed cerebral NAD+ elevation and altered metabolic gene expression, though clinical outcomes were not the primary endpoint (Brakedal et al., Cell Metabolism, 2022).

Direct peer-reviewed evidence on subcutaneous or intramuscular injectable NAD+ — the formulation most often offered locally — is far thinner than the oral-precursor literature. Reported clinical uses have focused on substance-use recovery and post-viral fatigue, generally without placebo control. A reasonable summary: the biology is well established; the injectable clinical evidence in healthy adults is preliminary.

Injectable NAD+ vs Oral Precursors

Patients in San Antonio often arrive at a consult having heard pitches for IV infusions, subcutaneous injections, oral NR/NMN capsules, and intranasal sprays. They are not interchangeable.

Oral precursors (NR, NMN, niacin, niacinamide) cross the gut wall and are converted to NAD+ inside cells via the salvage pathway. They have the most published human pharmacokinetic data.

Injectable NAD+ delivers the intact coenzyme. The pharmacokinetic question — whether circulating NAD+ enters cells efficiently or is broken down extracellularly first by enzymes like CD38 — is still actively researched. Some clinicians frame injectables as a way to bypass first-pass gut metabolism; published controlled comparisons in humans are limited.

IV NAD+ infusions typically deliver larger doses over hours and were originally adopted in addiction-medicine clinics. Adverse effects reported anecdotally include flushing, nausea, and chest pressure during rapid administration.

A clinician weighing these options considers the patient's goal, comorbidities, current medications, and what the supporting evidence does and does not say. The NAD+ Injectable program at Body Good Men routes that conversation to a US-licensed provider.

How a San Antonio Clinician Evaluates a Candidate

A thoughtful intake covers more than symptoms. Expect a clinician to review:

• Baseline labs — CBC, comprehensive metabolic panel, vitamin B12, fasting glucose, and often HbA1c. NAD+ blood-level testing exists commercially but is not yet a clinical standard.
• Medication and supplement history — particularly anything affecting methylation (B12, folate, methionine), since NAD+ metabolism intersects with the methyl-donor pool.
• Medical history — kidney function, liver function, cardiovascular history, and any prior reaction to vitamin or peptide injections.
• Goal alignment — whether the patient is pursuing energy support during a high-intensity training cycle, post-illness recovery, or a longevity-focused regimen.

The South Texas climate adds practical context. San Antonio summers regularly exceed 100°F, and patients training outdoors are at elevated risk of dehydration and electrolyte imbalance. A clinician may address those basics — sleep, hydration, training load, alcohol use — before adding any peptide or coenzyme injection. Texas also has a large active-duty and veteran population at Joint Base San Antonio; service members on active duty should clarify how a compounded therapy interacts with command policies before initiating treatment.

For readers comparing options, the men's recovery catalog at Body Good Men lists the formulations a clinician may discuss alongside lifestyle workup.

What to Ask Your Provider Before Starting

A short list worth bringing to the consult:

1. What is the published evidence specifically for injectable NAD+ at the dose you are recommending, and what is extrapolated from oral-precursor studies?
2. How will we measure response — symptom diary, functional testing, repeat labs, or none?
3. What duration of trial is reasonable before reassessing whether the therapy is providing meaningful benefit?
4. Are there interactions with my current medications, particularly anything affecting methyl-donor balance?
5. What side effects should I watch for, and at what point do I stop and call?

A clinician confident in the therapy answers these directly. If the consult feels rushed or the answers are vague, that is information.

The licensed clinician evaluation through the NAD+ Injectable program is structured to surface those answers in writing before any prescription is issued.

Common Misconceptions About NAD Therapy

"NAD injections reverse aging." No published human trial demonstrates reversal of biological aging endpoints from NAD-raising therapy in otherwise healthy adults. The cellular biology is plausible; the clinical proof is not yet there.

"More is better." Higher doses of NR have not produced linearly larger NAD+ rises in human studies, and CD38 activity may scale with substrate availability. Dosing is a clinical decision, not a do-it-yourself optimization.

"If it's a vitamin, it's safe at any dose." Niacin in high doses causes flushing and, less commonly, hepatotoxicity. Subcutaneous and intramuscular NAD+ preparations have a distinct side-effect profile — local site reactions, transient flushing, and rare hypersensitivity. These are not over-the-counter products.

Frequently Asked Questions

What is NAD injection therapy?

NAD injection therapy delivers nicotinamide adenine dinucleotide — a coenzyme central to cellular energy metabolism and DNA repair — by subcutaneous or intramuscular route. The goal is to raise tissue NAD+ levels, which decline with age in preclinical models. Most clinical efficacy data is on oral precursors like NR and NMN; injectable evidence in healthy adults is more limited and protocol-dependent.

How long does it take for NAD injections to work?

Patients describe variable timelines, and there is no published standard. Subjective reports of energy or sleep changes typically fall in the first few weeks of consistent use. Because controlled trials of injectable NAD+ in healthy adults are limited, expectations should be calibrated to what the evidence supports rather than to marketing claims. Discuss measurable endpoints with your clinician at the start of any trial.

Are NAD injections safe?

Reported adverse events from injectable NAD+ in clinical practice include injection-site reactions, transient flushing, mild nausea, and rare hypersensitivity. Long-term safety data is limited. A licensed clinician will screen for kidney and liver disease, current medications, and allergy history before starting therapy and will monitor for tolerance. Patients with significant comorbidities or unclear histories may not be appropriate candidates.

Where can I get NAD injections in San Antonio?

Functional-medicine and IV-therapy clinics across San Antonio offer NAD+. Telehealth platforms also evaluate eligibility online and ship compounded NAD+ from a partner pharmacy after a clinician review. The treatment decision rests with the licensed clinician evaluating you, not the dispensing channel. Verify the clinician's credentials and the pharmacy's licensure before initiating any compounded therapy.

What's the difference between IV NAD and NAD injections?

IV NAD+ infusions deliver larger doses over hours via a clinic visit. Subcutaneous or intramuscular injections deliver smaller doses, often self-administered between clinic visits at home. The pharmacokinetic differences matter for how a clinician structures a protocol. There is no consensus that one route is superior for healthy adults; the choice is a clinical judgment call informed by goal and history.

If you are considering NAD+ injection therapy and want to know whether it is appropriate for you, talk to a licensed clinician. The NAD+ Injectable program at Body Good Men connects you with a US-licensed clinician who reviews your eligibility and, if appropriate, prescribes through our partner pharmacy.

Important Disclosure

men.joinbodygood.com is operated as an affiliate of Body Good Studio LLC and is a whitelabel certified partner of Leg Up Rx. men.joinbodygood.com does not provide medical services, prescribe medications, or maintain patient records. All clinical evaluations, prescription decisions, and medication fulfillment are handled by licensed medical and pharmacy partners through Leg Up Rx. This article is for general informational purposes only and is not medical advice. Talk to a licensed healthcare provider before starting any treatment. Eligibility for any medication is determined solely by a licensed clinician.